Dock Street Asset Management Inc Soligenix, Inc. Transaction History

Dock Street Asset Management Inc

  • $725 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 14, 2022
SELL
$0.66 - $1.1 $14,850 - $24,750
-22,500 Closed
0 $0
Q2 2021

Jul 15, 2021
SELL
$0.87 - $1.58 $4,350 - $7,900
-5,000 Reduced 18.18%
22,500 $25,000
Q1 2021

Apr 15, 2021
BUY
$1.31 - $2.35 $36,025 - $64,625
27,500 New
27,500 $42,000

Others Institutions Holding SNGX

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About SOLIGENIX, INC.

SNGX Quotes by TradingView
  • Ticker SNGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,105,200
  • Market Cap $125M
  • Description
  • Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has c...
More about SNGX
Track This Portfolio

Track Dock Street Asset Management Inc Portfolio

Follow Dock Street Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dock Street Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Dock Street Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email